Fmoc-L-beta-HTyr(tBu)-OH

Fmoc-L-beta-HTyr(tBu)-OH is an Fmoc-protected, side-chain protected tyrosine derivative in which the phenolic oxygen is masked as a tert-butyl ether, preserving the aromatic hydroxyl functionality for later controlled deprotection. The molecule retains the L-configuration at the amino acid stereocenter and presents a β-hydroxy substitution pattern relative to the tyrosine backbone, which can influence conformational preferences and coupling reactivity during peptide assembly. The Fmoc group provides an orthogonal base-labile N-protection strategy compatible with standard solid-phase peptide synthesis, while the tBu ether is acid-labile and can be removed under conditions that leave the Fmoc strategy manageable through stepwise deprotection logic. The combination of an activated carboxylate (as an amino acid building block) with protected phenolic and β-hydroxy functionality makes the compound a chiral intermediate suited to peptide construction, amino acid derivatization, and downstream functional group transformations.

1. Peptide Synthesis

Fmoc-L-beta-HTyr(tBu)-OH supports peptide building block preparation for automated and manual peptide synthesis workflows where N-Fmoc protection enables orthogonal deprotection cycles. The Fmoc carbamate protects the α-amine during coupling, while the tert-butyl-protected phenolic oxygen and the β-hydroxy substitution provide handles for chemoselective protection management across peptide sequences. The L-stereochemistry is retained through the building block stage, allowing stereochemically defined incorporation into peptide chains and enabling controlled formation of amide bonds at the carboxyl terminus. Side-chain protection strategies help minimize undesired phenol or hydroxyl side reactions during coupling and deprotection, supporting the synthesis of tyrosine-containing analogs and β-functionalized peptide scaffolds. The resulting peptide intermediates can be carried forward to structure-activity relationship studies and biochemical probe development requiring defined hydroxyl-bearing motifs.

2. Side-Chain Functionalization

Fmoc-L-beta-HTyr(tBu)-OH functions as a protected amino acid intermediate for side-chain functionalization strategies that rely on staged unveiling of reactive oxygen functionalities. The tert-butyl ether masking on the tyrosine phenol and the presence of a β-hydroxy group enable selective conversion into ether, ester, or conjugation-ready derivatives after controlled deprotection. The Fmoc group allows the compound to be incorporated into peptides or kept as a chiral intermediate, then deprotected to expose the amine for subsequent derivatization or to enable peptide-based functional group installation. The defined stereocenter and protected oxygen pattern can be leveraged to generate hydroxyl-functional peptidomimetics, affinity ligands, or crosslinking precursors with reproducible substitution patterns. Downstream transformations can include formation of activated esters or linkers for conjugation chemistry, supporting synthetic organic chemistry programs that require hydroxyl-bearing chiral motifs.

3. Bioconjugation Chemistry

Fmoc-L-beta-HTyr(tBu)-OH can be applied in bioconjugation chemistry where hydroxyl-functional amino acid residues are used to build stable linkages to biomolecules. The protected phenolic oxygen and β-hydroxy functionality provide orthogonality for stepwise deprotection and coupling to electrophiles such as activated carbonyls, halides, or linker reagents under conditions that preserve other functional groups. The Fmoc-protected N-terminus supports peptide or linker assembly, enabling conjugation-ready constructs that can be generated by releasing the protected oxygens at the appropriate stage. The L-configuration and protected side-chain pattern help maintain defined stereochemistry in the conjugate scaffold, which is relevant for reproducible molecular recognition in chemical biology workflows. The compound thereby serves as a chiral precursor for constructing conjugation handles, including peptide-based tags, hydroxyl-reactive linker modules, and biomolecule labeling intermediates.

4. Peptidomimetics And SAR Studies

Fmoc-L-beta-HTyr(tBu)-OH is suitable for peptidomimetic construction and structure-activity relationship studies that require hydroxyl-bearing aromatic residues with controlled stereochemical placement. The β-hydroxy substitution pattern relative to the tyrosine backbone can influence hydrogen-bonding networks and local conformational behavior when incorporated into peptide analogs or constrained scaffolds. The Fmoc protection supports sequential assembly of analog series, while the tert-butyl-protected phenolic oxygen allows late-stage unveiling to tune polarity, reactivity, or conjugation state without perturbing earlier synthetic steps. The resulting analogs can be used to generate matched series differing in side-chain oxygen availability, enabling SAR investigations focused on how hydroxyl functionality and aromatic character affect binding or recognition in biochemical assays. This workflow aligns with amino acid chemistry practices where protected building blocks enable systematic variation of functional groups for downstream analytical and medicinal chemistry research.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-L-beta-HTyr(tBu)-OH can be used as a manufacturing-relevant amino acid building block for producing protected peptide intermediates in fine chemical and pharmaceutical manufacturing settings. The Fmoc carbamate and tert-butyl ether protection scheme supports process-friendly, stepwise deprotection logic that can be integrated into controlled synthetic sequences for generating defined peptide segments. The stereochemically defined L-configuration reduces the need for stereochemical correction at later stages, supporting consistent quality for downstream peptide coupling and final deprotection. The protected hydroxyl and phenolic functionalities help limit side reactions during scale-up coupling operations, supporting the preparation of intermediates used in peptide-based active ingredient synthesis or peptide-derived materials. The compound thus serves as a chiral intermediate aligned with industrial amino acid derivative handling, where protection strategy and functional group stability are central to reliable downstream processing.

1. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

2. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

3. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

4. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

5. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats